key: cord-1002148-3mntzzxi
authors: Rhoades, Raina; Solomon, Sarah; Johnson, Christina; Teng, Shaolei
title: Impact of SARS-CoV-2 on Host Factors Involved in Mental Disorders
date: 2022-04-04
journal: Front Microbiol
DOI: 10.3389/fmicb.2022.845559
sha: aa93a939256efbc0526ceb0253e5ad37583c529c
doc_id: 1002148
cord_uid: 3mntzzxi

COVID-19, caused by SARS-CoV-2, is a systemic illness due to its multiorgan effects in patients. The disease has a detrimental impact on respiratory and cardiovascular systems. One early symptom of infection is anosmia or lack of smell; this implicates the involvement of the olfactory bulb in COVID-19 disease and provides a route into the central nervous system. However, little is known about how SARS-CoV-2 affects neurological or psychological symptoms. SARS-CoV-2 exploits host receptors that converge on pathways that impact psychological symptoms. This systemic review discusses the ways involved by coronavirus infection and their impact on mental health disorders. We begin by briefly introducing the history of coronaviruses, followed by an overview of the essential proteins to viral entry. Then, we discuss the downstream effects of viral entry on host proteins. Finally, we review the literature on host factors that are known to play critical roles in neuropsychiatric symptoms and mental diseases and discuss how COVID-19 could impact mental health globally. Our review details the host factors and pathways involved in the cellular mechanisms, such as systemic inflammation, that play a significant role in the development of neuropsychological symptoms stemming from COVID-19 infection.

Post-acute COVID-19 Syndrome, also known as long-COVID, is a significant concern for global public health. The symptoms of long COVID range from length recovery from organ damage, persistent symptoms lasting up to 6 weeks, to a patient presenting as asymptomatic or experiencing a period of healing only to see a return of symptoms that persist from 3 to 6 months, and even sudden death up to 12 months post-infection (Raveendran and Misra, 2021) . Neurological and neuropsychiatric symptoms have also been observed in one-third of patients after COVID-19 infection (Schou et al., 2021) . These symptoms include depression, anxiety, cognitive deficits, "brain fog, " and fatigue, which have been reported in conjunction with infection by MERS-CoV and SARS-CoV and previous pandemics such as the Spanish Flu (Schou et al., 2021; Stefano, 2021) .

Studies have shown that some coronaviruses can invade the brainstem via a synapse-connected route from the lungs and airways . A few central mechanisms have been proposed to explain neurological symptoms related to SARS-CoV-2 infection. The first theory, the "indirect attack theory, " proposes that neurological effects are due to the immune impacts triggered by infections, i.e., the cytokine storm (Wu et al., 2020b) . The second suggests that the virus gains entry to the central nervous system (CNS) via the olfactory pathway, or peripheral route, and demonstrated in animal models of encephalitis induced by corona viral infection. The reports of deficits in taste, smell, and psychiatric symptoms following coronavirus infection are consistent with the peripheral route or the olfactory pathway as a route of entry for the SARS-CoV-2 virus (Acharya et al., 2020; Butowt and von Bartheld, 2020) . Anosmia and other deficits in sensation are features of several mental disorders, including post-traumatic stress disorder (PTSD), major depression disorder (MDD), SCZ, bipolar disorder (BPD), and neurodegenerative disorders. The third route of entry for SARS-CoV-2 into the CNS involves exosomes. Several studies have noted that the cytokine storm cannot explain CNS damage since the inflammatory markers seen in SARS-CoV-2 cases are less abundant than seen in other cases of a viral infection such as H1N1 influenza. Additionally, the lack of detected viral gene expression in the CNS casts doubt on the hypothesis that the cytokine storm is causing or leading contributor to the neurological damage and neuropsychiatric symptoms seen in some SARS-CoV-2 cases. Exosomes have been previously reported to aid in viral pathogenesis (Estrada, 2021) .

Viral entry of the coronavirus is mediated by the spike (S) protein, which has two subunits, S1 and S2. The S1 component binds to the host cell receptor, and the S2 subunit mediates the fusion of the virus with the host's cell membrane. The key to the entry of the SARS-CoV-2 virus into host cells is the angiotensinconverting enzyme 2 (ACE2) receptor, which is expressed in many tissues, including the respiratory system and neurons, and brain endothelium (Hamming et al., 2004; Sheraton et al., 2020) . However, viral entry is also dependent on the priming of the S protein by host proteases such as transmembrane serine protease 2 (TMPRSS2) and FURIN. Several virion components linked to the pathology of coronaviruses have also been previously linked to mental health disorders. Coronavirus proteins such as the envelope (E) and nucleocapsid (N) proteins have also been demonstrated to bind to post-synaptic density-95 (PSD-95) and retinoic acid-inducible gene-1 (RIG-1) proteins. The envelope protein of SARS CoV-2 has also been reported to have a PSD-95 binding motif. PSD-95 is a scaffolding protein that plays an essential role in excitatory neurons and viral pathogenesis (Javier and Rice, 2011) . Previous investigations have shown that the N protein of SARS-CoV-1, 90% similar to that of SARS-CoV-2, halts cell cycle progression in vitro (Li et al., 2005a,b; Dutta et al., 2020) . Additionally, the SARS-CoV-2 N protein has been shown to possess a RIG-1 binding domain and inhibit RIG-1-like pathways (Oh and Shin, 2021) . Rig-1 is a gene that recognizes viral infection, such as in Toxoplasma gondii. The Rig-1 gene has also been found to be associated with schizophrenia (SCZ) diagnosis (Carter, 2009 ). Additionally, the N-protein activates the cyclooxygenase-2 (COX-2) promoter. Thus, it plays a role in increased inflammation associated with coronavirus infection (Yan et al., 2006) . Host receptor ACE2 serves as the point of entry for SARS-CoV-2 via the attachment of the S glycoprotein (Krassowski et al., 2018) . A genome-wide association study of 1980 patients infected with SARS-CoV-2 found two loci 3p21.31 and 9q34.2 with genome-wide significance to be associated with severe symptoms. The significant association at the 3p21.31 locus was driven by solute carrier family 6 member 20 (SLC6A20), leucine zipper transcription factor-like 1 (LZTFL1), C-C chemokine receptor 1 (CCR1), FYVE coiled-coil domain-containing protein 1 (FYCO1), CXC motif chemokine receptor 6 (CXCR6), and X-C motif chemokine receptor 1 (XCR1), and the gene contributing to the significant association in the 9q34.2 locus was the histoblood group ABO system transferase (ABO) (Severe Covid-19 GWAS Group et al., 2020) . Additionally, five genes that seem to facilitate infection of the SARS-CoV2 virus are glycogen synthase kinase 3 beta (GSK-3β), furin protease, TMPRSS2, a disintegrin and metalloprotease 17 (ADAM17), and neuropilin-1 (Heurich et al., 2014; Cantuti-Castelvetri et al., 2020; Coutard et al., 2020; Nowak and Walkowiak, 2020) .

With this in mind, we must now consider how these viral pathways can activate mental health disorders, as links between infectious disease and mental health disorders have been previously reported. Increased risk of developing SCZ, for example, has been linked to several contagious agents such as Chlamydia spp., T. gondii, Human Herpesvirus, and Cytomegalovirus (Arias et al., 2012) . Coronavirus infection could lead to injury and inflammation, the exacerbation of neuropsychiatric symptoms. Studies of the olfactory epithelia have demonstrated its utility in studying psychiatric disorders as well as neurodevelopmental processes. Deficits in olfactory functioning have been reported in depression and other affective disorders (Taalman et al., 2017; Kamath et al., 2018) . Therefore, several proteins affected by coronavirus infection, such as ACE2 and dipeptidyl peptidase 4 (DPP4), are enriched in the epithelia of the respiratory tract (Hamming et al., 2004; Jia et al., 2005; Solerte et al., 2020) . Previous work has also reported several genes that may be related to increased susceptibility or resistance to SARS-CoV-2 infection (Wei et al., 2021) . And there are several suggested mechanisms by which SARS-CoV-2 may affect the CNS, such as "viral encephalitis, systemic inflammation, organ dysfunction, and cerebrovascular change" (Heneka et al., 2020) . This suggests that investigating genes enriched in the respiratory tract or found to be important in SARS-CoV-2 infection may help to understand how coronavirus infections may impact mental health (Wei et al., 2021) .

Depression is among the top five leading causes of disability worldwide. Mental health disorders have a significant impact on the global economy, costing as much as 2.5 trillion dollars per year and rising (GBD 2016 Disease and Injury Incidence and Prevalence Collaborators, 2017; The Lancet Global Health, 2020). Therefore, particularly imperative to understand how infectious diseases might be converging with social, economic, and life stressors that are perturbed during global pandemics. Fear, social isolation, anxiety, sleep disturbances, unemployment, and housing insecurity can compound ongoing or predisposed mental health issues. For example, it has been reported in Wuhan, China, that more than half of the residents experienced symptoms of depression and or anxiety (Clemente-Suárez et al., 2021) . Many recovered COVID-19 patients have been reported to experience neurological symptoms such as parkinsonism, intracranial hemorrhaging, and strokes. Long-term psychological symptoms such as dementia, anxiety, and psychosis have also been reported (Taquet et al., 2021a) . A retrospective cohort study of 62,354 patients showed that hazard ratios for psychiatric diagnoses were higher than influenza, skin infections, and respiratory tract infections for the first 14-90 days following COVID-19 diagnosis (Taquet et al., 2021b) . In a retrospective study of 236,379 patients, the authors found that the incidence of neurological and psychological symptoms in the 6 months following COVID-19 diagnosis was between 33 and 62%. Many of these patients were diagnosed with these symptoms for the first time, with an estimated incidence of 1-84% (Taquet et al., 2021a) . Additional studies have found that patients with long-COVID have exhibited imbalance, vertigo, hallucinations, headaches, memory deficits, and depression (Mehandru and Merad, 2022) .

Despite the production of several SAR-CoV-2 vaccines, the SARS-CoV-2 virus will likely become endemic (Shaman and Galanti, 2020; Veldhoen and Simas, 2021) . We, therefore, must study and develop an understanding of how infectious diseases like SARS-CoV-2 may contribute to long-term conditions such as mental health. The following review aims to highlight genes perturbed by a corona viral infection that are also implicated in mental disorders, emphasizing the effects of the SARS-CoV-2 virus. We begin by discussing host proteins vital to viral entry, a discussion of host proteins and factors that are affected downstream. Finally, we conclude by discussing how these host proteins relate to the etiology of mental health disorders (Figure 1 ).

SARS-CoV-2 exploits several proteins, including host proteases and host receptors, to gain entry to cells. The S protein, by which the virion enters host cells, must be cleaved by host proteases. Once the S protein has been primed, the protein can then bind host receptors, and the virion can then fuse with the host membrane. These host proteins vary in their spatial-temporal expression, but they each play a role in inflammatory responses, among other physiological effects. Understanding the functional functions of these entry proteins is crucial in understanding their role in the SARS-CoV-2 infection ( Table 1) .

The SARS-CoV-2 S protein must be primed by host proteases before it can bind to host receptors and infect cells. The host proteases that have been identified in helping aid in the binding of the S protein to host receptors include TMPRSS2, ADAM10/17, and Furin (Hussain et al., 2020) . TMPRSS2 was found to increase viral entry into host cells significantly and is expressed in astrocytes and oligodendrocytes (Heurich et al., 2014; Dong et al., 2020) . Previous work has demonstrated that camostat mesylate, a TMPRSS2 inhibitor, resulted in the blockage of SARS-CoV-2 into TMPRSS2 + cells (Hoffmann et al., 2020) . ADAM-10/17 (A disintegrin and metalloprotease 10 and 17) are proteases that cleave the extracellular domain of ACE2. However, they are reportedly less efficient than TMPRSS2 (Heurich et al., 2014; Aljohmani and Yildiz, 2020) . FURIN also aids SARS-CoV-2 entry. The FURIN protein is an endoprotease and is expressed in hippocampal and cortical neurons (Yang et al., 2018) . FURIN cleaves proteins within a specific motif (R/K)-(2X) n-(R/K) and plays a role in priming the SARS-CoV at the S1/S2 site (Coutard et al., 2020) . This cleavage allows the virus to shed the spike protein and enter the host cell. The use of the protease is thought to be a key component of the pathogenicity of many viruses, including SARS-CoV-2 infection (Coutard et al., 2020; Fitzgerald, 2020) . Of the known pathogenic beta coronaviruses, only the SARS-CoV2, MERS-CoV, and HCoV-OC43 viruses possess the FURIN cleavage complex motif. This protease also plays a role in apoptosis, inflammation of the vasculature, and lipid metabolism .

With SARS-CoV-2 ACE2 is a part of the renin-angiotensin-aldosterone system (RAAS), and it is the principal host receptor used by SARS-CoV-2 (Motaghinejad and Gholami, 2020) . The RAAS functions to maintain blood pressure by regulating fluid and electrolyte balance and vascular diameter (Wiese et al., 2020) . The SARS-CoV-2 infection leads to the downregulation of ACE2, leading to what is referred to as Angiotensin II intoxication (Sfera et al., 2020; Wiese et al., 2020) . ACE2 is expressed throughout the epithelia of the respiratory tract. However, the expression of ACE2 can be described as a gradient, where it is highest in the proximal nasal epithelia and attenuates as one proceeds to the epithelia of the lower respiratory tract . Within the central nervous system, the ACE2 receptor is expressed in both neurons and glial cells (Venkatakrishnan et al., 2020) . It is also important to note that the expression of ACE2 and TMPRSS2 also increases with age, according to an investigation of temporal expression profiles in mice at ages 2 months and 2 years (Bilinska et al., 2020) . Androgen receptor Depression Bipolar Increased levels of AR expression were reported in patients with bipolar disorder.

Positively and statistically significantly associated with depression risk (p = 0.003) in all women. Colangelo et al., 2012 Schizophrenia In a study of schizophrenic male patients and a group of undiagnosed adults, both treated and untreated patients had lower serum levels of SHBG than undiagnosed controls.

Mental disorders TGF-beta Schizophrenia and psychosis TGF-Beta plays a role in the immune-inflammatory response and the compensatory immune-regulatory reflex system, which contribute to the etiology of schizophrenia. Roomruangwong et al., 2020 DPP4 is a ubiquitously expressed serine protease that plays a role in inflammation energy metabolism and has also been reported as a marker of senescence (Klemann et al., 2016; Kim et al., 2017; Shao et al., 2020; Rohmann et al., 2021) . The DPP4 protein is widely expressed in many cell types throughout the CNS, including dopaminergic neurons, macrophages, and glia (Venkatakrishnan et al., 2020) . Although it is primarily known as the host receptor utilized by the MERS-CoV virus, previous work has shown that SARS-CoV-2 may also use as a point of entry. A protein docking simulation and subsequent analysis of free energy binding found that SARS-CoV2 bound firmly to DPP4 . It is worth noting that the RAAS system and the DPP4 receptor are dysregulated in diabetes, a risk factor in severe COVID illness (Valencia et al., 2020) .

Lymphopenia is one of the symptoms seen in patients with COVID-19. This observation has led to the notion that SARS-CoV-2 might also utilize other receptors, like XCR1, to facilitate T-Cell entry (Mobini et al., 2021) . A structural study of binding affinity found that XCR1, in addition to several chemokine and immune receptors, had a higher binding affinity for the SARS-CoV-2 S protein than ACE2. XCR1 and other chemokine receptors are present in many types of immune cells. The XCR1 gene is upregulated in response to traumatic brain injury (Mobini et al., 2021) . Several other chemokines, as well as their receptors, have been linked to prognostic outcomes in SARS-CoV and MERS-CoV infection (Khalil et al., 2021) .

Neuropilin is a host receptor that concretizes the overlapping impacts of SARS-CoV-2 infection as it plays a role in the inflammatory response, angiogenesis, and nerve growth, as well as synaptogenesis (Cai and Reed, 1999; Mayi et al., 2021) . Investigators who used x-ray crystallography were able to demonstrate that SARS-CoV-2 spike protein cleaved at the furin site was able to bind with neuropilin (NRP1) (Daly et al., 2020) . Neuropilin is known to bind proteins cleaved by FURIN protease. In an investigation of host cell entry, the authors used HEK-293 T cells transfected with plasmids to permit the expression of ACE2 and NRP1 (Cantuti-Castelvetri et al., 2020) . Furthermore, comparative analysis of postmortem olfactory epithelium from COVID-19 patients and uninfected controls showed that SARS-CoV-2 could infect NRP1 positive cells of the olfactory epithelium (Cantuti-Castelvetri et al., 2020) . Although the levels of ACE2 in the cells of the olfactory epithelium were relatively low, the authors found that expression levels of high levels of NRP1 and oligodendrocyte transcription factor (OLIG2), a marker for neuronal progenitors of the olfactory tract, were higher by comparison (Cantuti-Castelvetri et al., 2020).

Once SARS-CoV-2 begins to proliferate and spread, innate immunity is deployed as T lymphocytes, and dendritic cells are activated by pattern recognition receptors like toll-like receptors (TLRs) (Bai et al., 2021) . However, this innate immunity is overcome by viral suppressors of RNAi (VSRs) (Bai et al., 2021) . This leads to the release of inflammatory factors, which in severe cases may lead to a cytokine storm, resulting in tissue damage to organs such as the lungs and heart (Mortaz et al., 2020) . These inflammatory factors and cytokines cause adaptive immune cell activation as CD4+ T-cells to act as antigen-presenting cells, and CD8+ T cells are deployed to kill infected cells (Mortaz et al., 2020) . Viruses like SARS-CoV-2 have evolved methods of evading host immunity and usurping cellular machinery involved in cell survival, senescence, autophagy, mitophagy, etc., to enable their proliferation (Alcock and Masters, 2021). These mechanisms are further impacted by age as well as hormone signaling. In this section, we explore the effects of SARS-CoV-2 entry and genes involved in the downstream process (Table 1) .

The TLRs are molecular pattern recognition receptors that help to monitor the external cellular environment for pathogenicassociated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPS) (Lim and Staudt, 2013; Kumar, 2019; Liu et al., 2019a) . The activation of TLRs following SARS-CoV-2 infection can incite a cytokine storm within the respiratory endothelia. However, it is also capable of activating glial cells of the CNS, releasing several inflammatory factors such as interleukin-1 (IL-1), IL-6, IL-12, C-X-C motif chemokine ligand 10 (CXCL10), C-C motif ligand 3 (CCL3), CCL5, CCL2, TNF-alpha, CXCR6, XCR1, and CCR1, causing chronic inflammation and brain damage (Bouças et al., 2020; Coperchini et al., 2020; Jakhmola et al., 2020; Wu et al., 2020b; Khanmohammadi and Rezaei, 2021) . Several of these chemokines and inflammatory factors are expressed in astrocytes, glia, neurons, neural stem cells, and oligodendrocytes (Sowa and Tokarski, 2021) . The cytokine storm, particularly the release of TNF-alpha, then leads to the suppression of B-cells and thus antibody production . One host protein that is critically involved in the cytokine storm is GSK-3β.GSK-3β is a serine-threonine kinase involved in the inflammatory response to infectious disease and plays a role in the phosphorylation of the SARS-CoV-2 N-protein. Inhibition of GSK-3β by drugs such as lithium has been demonstrated to reduce viral replication and enhance immune response (Taylor et al., 2016; de Souza et al., 2020; Rana et al., 2021) . Human Leukocyte Antigen (HLA) also plays a key role in genes regulating the immune response to pathogens through antigen presentation. However, the effect of HLA variants on susceptibility and resistance in coronavirus infection is less evident in the case of SAR-CoV-2 infection (Saulle et al., 2021) . For example, the HLA-A * 24:02 allele was reported to be both a contributing factor to susceptibility and resistance to SARS-CoV-2 infection in separate investigations (Saulle et al., 2021) .

The pro-inflammatory High Mobility Group Box 1 (HMGB1) is a non-histone protein that also provides an entry point for SARS-CoV-2 (Andersson et al., 2020) . HMGB1 is involved in organizing chromatin but acts as a damage signal when released by cells, such as neurons and glia, under conditions of stress or inflammation (Paudel et al., 2018) . When necrotic cells release DAMP and PAMP molecules in the extracellular milieu, they can bind with HMGB1. These complexes of HMGB1 and DAMP and PAMP signals are then taken up by the cell through endocytosis and translocated to lysosomes. This activity leads to increased proinflammatory effects by breaking down the lysosomal membrane and releasing cytokines and other factors into the cytosol (Andersson et al., 2020) . The extent to which chloroquine compounds may provide some benefit in COVID infections is that they might prevent the transfer of PAMPs and DAMPs containing SARS-CoV-2 RNA to the cytosol (Andersson et al., 2020) .

Previous reports have demonstrated correlations between severe SARS-CoV-2 infection and cell cycle arrest in the S/G2 phase (Suryawanshi et al., 2021) . For example, the C-terminus of the E-protein of the SARS-CoV and SARS-CoV-2 shares a very similar motif to the N-terminus of histone 3 (Gordon et al., 2020) . Recently several proteins involved chromatin remodeling were identified in a genome-wide CRISPR screen in Vero-E6 cells infected with SARS-CoV-2, MERS-CoV, bat HKU5 expressing the SARS-CoV-1 S protein, and the vesicular stomatitis virus expressing the SARS-CoV-1 S protein. The authors found that AT-rich interactive domain-containing protein 1A (ARID1A) was a pro-viral gene in the case of infection by SARS-CoV-2 and MERS-CoV viruses (Wei et al., 2021) . ARID1A/B is a component of the mammalian BRG1/BRM (BAF) complex, involved in chromatin remodeling and cell cycle arrest (Shigetomi et al., 2011; Pagliaroli and Trizzino, 2021) . ARID1A is ubiquitously expressed in neural stem progenitor cells and throughout the brain . Another cellular component found to be perturbed by SARS-CoV-2 infection was the SWI/SNF (SWItch/Sucrose Non-Fermentable) complex, which is responsible for ATPdependent chromatin remodeling. Interference with cell cycle progression allows the SARS-CoV-2 to hijack cellular machinery to increase viral replication .

Bone-derived neurotrophic factor (BDNF) is a growth factor that plays a role in neurotransmission and neuroplasticity. It is expressed throughout the brain, including in astrocytes, Schwann cells, and neurons (Sakharnova and Vedunova, 2012) . BDNF binds to tyrosine kinase B (Trk B), initiating a signal cascade that leads to the activation of the mechanistic target of rapamycin (mTOR), which promotes survival, growth, and differentiation of neurons (Bar-Yosef et al., 2019) . SARS-CoV-2 has been demonstrated to enhance mTOR complex 1 (mTORC1) activity (Bar-Yosef et al., 2019). Calmodulin is not only an essential regulator of cellular activity, including apoptosis, neurotransmitter release, etc. (Yu et al., 2002; Ando et al., 2013; Schweitzer et al., 2021) . Solute carrier family six-member 20 (SLC6A20) plays a role in the regulation of glycine as well as N-methyl-D-aspartate (NMDA) signaling (Bae et al., 2021) .

SARS-CoV-2, like many other viruses, is thought to induce senescence in host cells through the increased binding of Angiotensin II (ANGII) to the Angiotensin II Type 1 receptor. ANGII acts as a toxin with respect to the host's cells' mitochondria through activation of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and the creation of reactive oxygen species (ROS), H 2 O s . This increase leads to the formation of hydroxyl radicals that cause DNA damage and the activation of poly ADP-ribose polymerases (PARPs), which are DNA damage sensors and deplete stores of NAD+ and exacerbate both the dysfunction of mitochondria. The depletion of NAD+ also results in the reduced mitophagy the increased formation of ROS, which in turn activates ADAM17 and inhibits nitric oxide (NO) synthesis (Dikalov and Nazarewicz, 2013; Chang et al., 2020; Sfera et al., 2020) . ADAM17 is also a metalloprotease that has been reported to prime the SARS-CoV-2 spike protein (Heurich et al., 2014) .

Autophagy plays an essential role in the homeostatic balance between cell survival and cell death. Previous work has shown that coronaviruses MERS-CoV and SARS-CoV can prevent autophagosomes from binding to lysosomes (Randhawa et al., 2020) . The SARS-CoV-2 infection has been shown to reduce zinc finger FYVE and coiled-coil domain-containing autophagy adaptor 1 (FYCO1) expression, which participates in autophagosome maturation through the Rab7 effector protein, a late endosomal GTPase (Cheng et al., 2007; Pankiv et al., 2010; Randhawa et al., 2020) . FYCO1 is expressed in several different cell types within the cortex (Mestres et al., 2020) . The cysteine proteases cathepsin B (CTSB) and cathepsin L (CTSL) have also been implicated, alongside TMPRSS2, in the activation of the S proteins of the SARS-CoV-1, SARS-Cov-2, and MERS-CoV coronaviruses. These proteases are found in endosomes/lysosomes and participate in autophagy and apoptosis (Pišlar et al., 2020) . Cathepsins consists of serine, aspartic, and cysteine proteases and are ubiquitously expressed (Vidak et al., 2019) . Although the cysteine cathepsins are primarily located within the lysosome, where the acidic environment maintains their stability, the excess secretion of cathepsins is associated with inflammatory responses and disease (Huang et al., 2006; Gomes et al., 2020; Pišlar et al., 2020) . Previous research has demonstrated host cell entry of coronapseudoviruses via CTSL dependent endocytosis, and cysteine protease inhibitors effectively blocked viral entry (Simmons et al., 2005 (Simmons et al., , 2011 Zhou et al., 2011; Rabaan et al., 2017) . Much like ACE2 and TMPRSS2, CTSB/L is enriched in the lungs (Darbani, 2020) . However, the gene expression of the CTSB/L in the cortex and cerebellum was greater relative to the gene expression of ACE2 and TMPRSS2, which were nearly undetectable in the same tissue (Darbani, 2020) .

Testosterone levels have emerged as a risk factor for severe SARS-CoV-2 infection, and sex hormone signaling genes have been identified in previous investigations as potential targets in the treatment of SARS-CoV-2. Androgen receptors (ARs) are expressed through the CNS; however, the cortical expression of the AR is higher relative to other structures (Schumacher et al., 2021) . The receptor influences the expression of ACE2 and TMPRSS2. Previous investigations of the effects of antiandrogenic drugs on the expression of genes related to the pathogenesis of SARS found that AR is a transcriptional regulator of ACE2, Furin, and TMPRSS2 (Samuel et al., 2020; Wambier et al., 2020) . The TMPRSS2 gene is a target of the androgen receptor, which enhances transcription of TMPRSS2 (Clinckemalie et al., 2013; Samuel et al., 2020) . It is, therefore, worth noting that hyperandrogenism in women has been associated with a greater risk of severe complications related to COVID-19 infection (Moradi et al., 2020) . Previous investigations have demonstrated that the estrogen receptor (ER) is expressed by all neural cells and plays a role in resistance to infection and influences cytokine and macrophage activity (Seli and Arici, 2002; Villa et al., 2016) . Interventions targeting estrogen and estradiol have been proposed as potential treatments for SARS-CoV-2 (Hussman, 2020). Sex-binding globulin (SHBG) is produced and secreted by the liver, and it binds sex hormones such as testosterone, and estrogen, thus regulating their levels in the bloodstream (Colangelo et al., 2012 ).

An observational study of COVID-19 patients found lower SHBG levels in patients who died.

Several of the host proteins genes that contribute to the pathobiology of SARS-CoV-2 infection, such as those involved in chromatin remodeling, are critical in the development of the central nervous system (Moffat et al., 2019; Torres-Berrío et al., 2019; Pagliaroli and Trizzino, 2021) . Other host proteases and cellular receptors are involved in neurodevelopment, cellular proliferation, neurotransmitter release, sympathetic nervous system activation, neuroinflammation, etc. (Seidah, 2011) . For example, factors involved in chromatin remodeling such as SWI/SNF and HMGB1 the SWI/SNF complex are important to embryonic and neurodevelopment. Dysfunction in genes associated with this complex are associated with neuropsychiatric disorders, neurodegenerative disorders, and intellectual disability (Marballi et al., 2014; Son and Crabtree, 2014; Vogel-Ciernia and Wood, 2014; Gozes, 2017; Paudel et al., 2018) . Meanwhile, markers of neuroinflammation like XCR1 and CCXR1 are also implicated in stress, infection, and traumatic brain injury (Ciechanowska et al., 2020) . These conditions lead to the presence of damage signals or antigens that can thereby be recognized by receptors such as toll-like receptors. The binding of these signal molecules then initiates signaling pathways, which lead to increased expression of inflammatory cytokines. This, in turn, leads to the activation of the hypothalamic-pituitary-adrenal (HPA) axis and sympathetic nervous system and the release of adrenaline, epinephrine, etc. (Canneva et al., 2015) . The SARS-Cov-2 infection has also been known to trigger Guillain-Barre Syndrome, an autoimmune disorder characterized by demyelination of peripheral nerve axons (Toscano et al., 2020) . Neuroinflammation and autoimmune disorders such as rheumatoid arthritis and celiac disease have been linked to mental health disorders such as BPD, SCZ, and psychosis (Eaton et al., 2010; Bergink et al., 2014; Dasdemir et al., 2016; Goldsmith et al., 2016; Hong et al., 2017; Milenkovic et al., 2019) . A study of a large cohort of 3.57 million births linked to the Psychiatric Care Register in Denmark found that the relative risk for individuals diagnosed with an autoimmune disorder to be diagnosed with SCZ was 1.2 (Eaton et al., 2010) . In this section, we examine the host factors that play critical roles in the etiology of mental disorders (Table 1) .

SARS-CoV-2 entry protein, ACE2, exert neuroinhibitory influence within brain regions such as the middle temporal gyrus and posterior cingulate cortex . Angiotensin (Ang) 1-7, a product of ACE2, decreases the synthesis and reuptake of noradrenaline and increases its uptake (Gironacci et al., 2014) . ACE-2 and Mas protein regulate brain function and release neurotrophic factors, like BDNF (Steenblock et al., 2020) . This factor has several critical roles, including the formation, development, and inhibition of degeneration of the neurons. It also plays a role in stabilizing mood and in cognitive function. Decreases in ACE-2 activity or expression have been known to disturb normal neurologic functions. This inhibition of ACE2 and subsequent decrease in BDNF leads to neurodegeneration and may cause mental disorders such as anxiety, depression, and cognitive impairment (Steenblock et al., 2020) . It is important to note that the AR regulates the expression of ACE2 and TMPRSS2. Both AR and TMPRSS2 are implicated in prostate cancer, and some data suggests that there may be an association between prostate cancer and depression and anxiety (Newby et al., 2015; Rice et al., 2018; Wang et al., 2020) .

Other host proteins such as neuropilin and DPP4 also relate to depressive symptoms. The expression of neuropilin in olfactory epithelia seems to be related to major mental disorders such as MDD. In one investigation, the authors found a significantly higher expression of NRP1 in post-mortem samples from the PFC of patients diagnosed with MDD when compared to controls (p < 0.001) (Goswami et al., 2013) . Similarly, the expression of neuropeptide Y (NPY), a ligand for the DPP4 receptor, has been proposed as a biomarker for diagnosing PTSD, depression, and other neuropsychiatric illnesses (Canneva et al., 2015; Schmeltzer et al., 2016; Gołyszny and Obuchowicz, 2019) . NPY has anxiolytic effects, and in an investigation, NPY immunoreactivity was significantly decreased in the cerebral spinal fluid (CSF) of unmedicated patients with persistent unipolar depression (Heilig et al., 2004) . There is currently a clinical trial underway to investigate the value of Vildagliptin, an anti-diabetic drug, as adjunctive therapy to the SSRI, Escitalopram, and PDE3 inhibitor, Cilostazol, for the treatment of MDD (Clinical Trial ID: NCT04410341). It is also worth noting that cathepsins play a role in processing proneuropeptides like neuropeptide Y and have been found to be moderately associated with higher cognitive function following exercise training (Funkelstein et al., 2008 (Funkelstein et al., , 2012 Moon et al., 2016) .

Neuroinflammatory and immune responses are known to contribute to the development of mental disorders. One investigation of postmortem tissue taken from the dorsolateral prefrontal cortex (DLPFC) found increased mRNA expression of TLR3 and TLR4 and the increased presence of pro-inflammatory factors in the brains of depressed non-suicidal, and suicidal subjects (Pandey et al., 2014) . Increased expression of TLR3 also results in reduced expression of disrupted in schizophrenia 1 (DISC1), which leads to aberrant neuronal morphology (Chen et al., 2017) . In fact, previous research has shown that treatment with endotoxin to stimulate inflammatory cytokines or even treatment with inflammatory kinases themselves can lead to symptoms of depression in people who were previously undiagnosed (Bonaccorso et al., 2002; Anttila et al., 2018) . Another investigation of the unfolded protein response in rats found increased expression of TLRs 2, 4, 7, and 9 as well as inflammatory cytokines within the hippocampus (Timberlake et al., 2019) . In patients with hepatitis C, interferon-alpha (IFN-α) treatment can lead to clinical symptoms of depression, which can be alleviated by antidepressant therapy. This finding suggests that depression is caused by inflammation, and typical presentations of depression may have some similar underlying mechanisms.

Expression of inflammatory markers, such as chemokine CXCR6, by meningeal γδ T cells, has been shown to influence anxiety in mice (Alves de Lima et al., 2020) . Mice deficient in CXCR6 have been demonstrated to have fewer γδ T cells than controls. The γδ T cells, in turn, release IL-17, a gene implicated in autism spectrum disorder (ASD) and SCZ (Debnath and Berk, 2017; Alves de Lima et al., 2020) . γδ T cell-deficient mice demonstrated reduced anxiety behavior in the open field test. The authors showed that these cells could control anxiety behavior through IL-17 signaling (Alves de Lima et al., 2020) .

Sex hormones and neuroimmune responses play converging roles in the etiology of mental disorders (Kokkosis and Tsirka, 2020) . Lower testosterone is a predictor of depression symptoms in men, while higher levers of free testosterone in serum have been linked to manic episodes in men (Ozcan and Banoglu, 2003; Sankar and Hampson, 2012) . Anti-androgenic therapies have been considered as a potential treatment for vulnerable populations (Bravaccini et al., 2021) . A greater risk of depressive symptoms was positively associated with SHBG in a study of depressive disorders in post-menopausal women. SHBG was positively and statistically associated with depression risk (p = 0.003) in all women (Colangelo et al., 2012) . In a study of schizophrenic male patients and a group of undiagnosed adults, the authors found that both treated and untreated patients had lower serum levels of SHBG (33.3 and 26.6 nmol/L) than undiagnosed controls (48.4 nmol/L, p < 0.05) (Costa et al., 2006) .

Several infections, such as cytomegalovirus, herpes simplex virus, and parasitic infection by T. gondii, have been noted for interacting with the HLA system and for their association with affective disorders like BPD and SCZ (Parks et al., 2018) . SCZ has been linked to several polymorphisms in the major histocompatibility complex (MHC) or the HLA system through several GWAS (Parks et al., 2018) . HLA genes are expressed in astrocytes and microglia within the brain, although primarily in microglia (Tian et al., 2012) . Previous investigations have identified HLA-B * 4601, HLA-B * 0703, HLA-B * 4601, HLA-C * 0801, and HLA-DRB1 * 1202 as alleles associated with severe illness following SARS-CoV-2 infection (Lin et al., 2003; Ng et al., 2004; Morsy and Morsy, 2021) . The HLA-DRB * 0301 and HLA-Cw * 1502 alleles were associated with a reduced frequency of severe infection. These clusters, namely HLA-B, HLA-DRB1, HLA-C, HLA-DRA, HLA-DQA, HLA-DQB, HLA-DPB, have been associated with mental health disorders, i.e., SCZ, BPD, and PTSD (Carter, 2009) . A genewide association study of 13,4982 cases and 663 controls found significant associations between the Notch 4 intronic variant rs3131296 and HLA alleles: HLA-DRB1 * 0301 and HLA-B * 0801 (R 2 = 0.86 and 0.81, respectively) (Stefansson et al., 2009) . In a separate investigation of molecular pathways underlying SCZ and BPD, the authors found that patients demonstrate more variation in the HLA-C and HLA-DRA genes than would be expected by chance (Marco et al., 2015) . It is also worth noting that PTSD has also been found to be associated with HLA alleles (HLA-B * 5801, HLA-C * 0701, HLA-DQA1 * 0101, HLA-DQB1 * 0501, and HLA-DPB1 * 1701) in a case-control study of 403 diagnosed patients with 369 individuals who had been exposed to trauma (Katrinli et al., 2019) .

Differential levels of cytokines and cytokine receptors have been found between the first episode, acute relapse of psychosis, and post-treatment patients diagnosed with SCZ (Capuzzi et al., 2017) . A previous meta-analysis of first-episode psychosis, acute relapse, and post-treatment SCZ patients compared effect sizes of blood levels of inflammatory markers (cytokines, cytokine receptors, and antagonists) (Miller et al., 2011) . Significant differences between the effect sizes of several inflammatory markers were found between post-treatment patients diagnosed with SCZ and first-episode psychosis and acutely relapsed patients (Miller et al., 2011) . These cytokines and receptors include including IL-6, IL-12, TNF-α, IL-1β, IL-8, transforming growth factor-β (TGF-β), IL-1RA, IFN-γ, sIL-2R, and IL-10 (Miller et al., 2011) . It is worth noting that levels of IL-6 and TNF-α were significantly correlated with survival in SARS-CoV-2 in a previous investigation (Del . Increased levels of circulating IL-1β, IL-12, IL-6, CXCL10, CCL2 have been reported in severe cases of SARS-CoV-2 infection (Coperchini et al., 2020) . TGF-beta plays a role in regulating immune response and plays a role in the development of mental disorders like SCZ and symptoms such as psychosis (Sanjabi et al., 2017; Roomruangwong et al., 2020) . Increased expression of chemokines such as CCR1 has been shown in postmortem brain tissue in patients diagnosed with SCZ compared to patients diagnosed with BPD (de Baumont et al., 2015) .

Metalloproteases ADAM10/17 have been implicated in neurodegenerative disorders. They play a role in the proteolysis of the amyloid precursor protein (APP) and several other proteins (Vincent and Govitrapong, 2011; Qian et al., 2016) . Similarly, another protein affected by SARS-CoV-2 infection, FYCO1, has been linked to neurodegenerative disorders, neuropsychiatric disorders, and senescence in age-accelerated mice (Cheng et al., 2007; Saridaki et al., 2018) . However, ADAM10/17 have also been linked to SCZ, depression, BPD, and conduct disorder, a condition that has been found to be comorbid with mood disorders (Jian et al., 2011; Marballi et al., 2012; Qian et al., 2016; Hoseth et al., 2017; Yuan et al., 2017; Pantazopoulos et al., 2020) . A family-based association study found 20 variants associated significantly associated with conduct disorder; among these single nucleotide polymorphisms (SNPs), rs383902 was located within ADAM10 (p = 0.00036) (Jian et al., 2011) . In one investigation of postmortem brain tissue from BA9, using ANCOVA analysis, investigators found a significant difference in ADAM17 expression between the control and bipolar groups and levels observed in the schizophrenic group (p < 0.007). The authors also found a significant negative correlation between levels of neuregulin-1 (NRG-1) and ADAM17 in Broca's area 9 samples taken from the post-mortem tissues of patients diagnosed with SCZ (Marballi et al., 2012) . Similarly, Hoseth et al. (2017) found greater mRNA expression of ADAM17 in the plasma of SCZ patients vs. that seen in controls (Hoseth et al., 2017) . ADAM10/17 influences glutamatergic signaling, which is also impacted by the SLC6A20 transporter protein. In a GWAS of NMDA receptors and the detection of their coagonists in cerebrospinal fluid, the authors found that a missense variant in SLC6S20 as associated with increased L-proline levels in CSF, thus demonstrating that SLC6A20 plays a role in the trafficking of proline to the CSF (Luykx et al., 2015) . Hyperprolinemia has been previously reported in conjunction with SCZ and schizoaffective disorder (Jacquet et al., 2005; Clelland et al., 2011) .

Neurotransmission may also be related to the expression of SARS-CoV-2 entry protease FURIN. FURIN was found among several genes linked to comorbidity SCZ and cardiometabolic illness, which gives insight into the etiology of these conditions . Several studies underscore the importance of furin in the CNS, as it has been linked to Alzheimer's disease (AD) and SCZ (Scamuffa et al., 2006; Schrode et al., 2019; Yang et al., 2020) . In a GWAS of 49 ancestry matched nonoverlapping case-controls and 1,235 parent affected offspring trios, the authors found 108 loci that were significantly associated with SCZ (Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014). Of those, Fromer et al. (2016) found nineteen of the SCZ risk loci were enriched for eQTLs. However, only eight involved a single gene; among them was the gene encoding furin protease. The authors found that furin expression was downregulated by the risk variant rs4702 (GG to AA allelic conversion), a 3 UTR variant, which was both the most significant SNP detected by GWAS and eQTL analyses (Fromer et al., 2016) . The rs4702 SNP results in the alteration in the binding site for miR-338-3p. miR-338-3p is an mRNA that is expressed predominantly in mature neurons within the dentate gyrus (Howe et al., 2017) . The authors noted that cells in which miR-338-3p was effectively knocked down showed aberrations in the number of primary dendrites as well as the angles of their extension from the soma (Howe et al., 2017) . Interestingly enough, the rs4702 variant, which is associated with SCZ, may be protective against SARS-CoV-2 infection, as cells expressing rs4702 had reduced levels of vRNA relative to cells expressing the normative allele (AA) (Dobrindt et al., 2021) . In a separate investigation, the rs4702 specific reduction in the expression of FURIN and BDNF was "mediated" by miR-338-3p (Hou et al., 2018) . BDNF is a member of the BDNF-mTORC1, which helps to regulate synaptic plasticity, glutamatergic signaling, monoaminergic signaling, and autophagy. The SARS-CoV-2 infection has been demonstrated to increase the activity of mTORC in Vero kidney epithelial cells 24 h post-infection (Mullen et al., 2021) . A common SNP of BDNF, rs62265, is a missense mutation that has been associated with anxiety, major depression, suicide, and neurodegenerative disease, as has dysregulation of mTOR signaling (Dincheva et al., 2016; Youssef et al., 2018; Bar-Yosef et al., 2019) . Additionally, decreased BDNF expression has also been associated with SCZ (Suchanek-Raif et al., 2020) . Epigenetic regulation of BDNF has also been demonstrated to play a role in mental illness, as methylation of genes associated with SCZ, like BDNF, has been linked to psychosis (Gavin et al., 2010) .

Increased levels of GSK-3β in blood, serum, and CSF have been associated with SCZ (Mohammadi et al., 2018) . The GSK-3β inhibitor lithium, which is utilized as a treatment for psychiatric disorders such as SCZ and BPD, has been shown to inhibit infection by several viruses, including coronaviruses (Murru et al., 2020) . One investigation examined gene expression in 12 BPD patients and ten controls following two laser microdissections of the olfactory epithelia: one pretreatment with lithium in the second after 6 weeks of daily lithium treatment. The BPD patients demonstrated greater levels of GSK-3β than controls (Narayan et al., 2014) . Lithium has been shown to inhibit GSK-3β, and similar to those studies the authors found that GSK-3β was reduced in the second microdissection samples taken from BPD patients following 6 weeks of daily lithium treatment (Harrison et al., 2007; Narayan et al., 2014; Zhao et al., 2017) .

Genes responsible for chromatin remodeling are implicated in SCZ as well. The SWI/SNF complex protein ARID1A is typically associated with craniofacial abnormalities. However, mutations in the ARID1B gene have been associated with intellectual disability, ASD, and SCZ as well (Son and Crabtree, 2014; Pagliaroli and Trizzino, 2021) . SWI/SNF-related matrixassociated actin-dependent regulator of chromatin, family a, member 2 gene (SMARCA2), encoding the SWI/SNF subunit, Brahma (BRM), has been associated with self-reported MDD and SCZ (Amare et al., 2020; Wu et al., 2020a) . In an investigation of bivariate analyses of genome-wide association study results relating to depression combined with MDD, BPD, and SCZ, the authors found that the SMARCA2 gene and the SWI/SNF gene set were enriched. This indicated the role of epigenetic mechanisms in the etiology of complex mental health disorders (Amare et al., 2020) . In a separate investigation, drugs capable of inducing psychosis were found to reduce BRM expression, while anti-psychotics led to increased expression of BRM (Koga et al., 2009) .

Further demonstrating the importance of chromatin remodeling proteins in the etiology underlying SCZ is the HMGB1 protein. An investigation of gene expression in postmortem tissue from 212 patients with SCZ and 214 undiagnosed controls found 87 genes demonstrated expression variability, including HMGB1 . In a separate study, serum levels of HMGB1 were significantly higher in bipolar patients than in undiagnosed controls. The authors found that serum levels of HMGB1 were significantly higher in the bipolar patients compared to the controls137. A systematic review of the literature also found increased levels of HMGB1 in conjunction with several studies of mouse models of depression . One drug, minocycline, was found to reduce depressivelike symptoms in a mouse model of depression. This reduction was associated with a significant decrease in the translocation of HGMB1 from neurons and microglia . Sex hormones have also been shown to play a role in the risk of developing SCZ (Kokkosis and Tsirka, 2020) . Women with polycystic ovarian syndrome (PCOS) have also been demonstrated to be at greater risk of developing psychiatric disorders such as bipolar disorder and SCZ (Owens et al., 2019 ). An investigation of androgen receptor expression among individuals diagnosed with SCZ, BPD, and undiagnosed controls (n = 35, 31, and 34, respectively) found increased expression of AR among individuals diagnosed with bipolar disorder relative to individuals diagnosed with SCZ and control volunteers. No significant differences were observed in 5α-reductase between the experimental groups. However, a small but significant correlation was found between bipolar disorder and 5α-reductase expression (r = 0.422, p < 0.01) (Owens et al., 2019) . Hormones have been demonstrated to affect neuropeptides involved in stress and anxiety, like oxytocin and corticotropin-releasing hormone (CRH) . Previous research has linked decreased oxytocin and oxytocin receptor levels to first-episode SCZ and bipolar II disorder (Liu et al., 2019b; Wei et al., 2020) . The therapeutic use of OXT has been proposed as a treatment to protect against cardiovascular damage caused by SARS-CoV-2 infection .

Several host genes affected by SARS-CoV-2 infection are implicated in mental disorders and neuropsychiatric symptoms. Of the host genes perturbed by the coronavirus spike protein, many are involved in innate and adaptive immunity, stress response, cell cycle regulation, and other biological functions. These genes have also been implicated in mental disorders such as depression, SCZ, and bipolar disorder. Other components of the SARS-CoV-2 virion, such as E and N proteins on host proteins PSD95 and RIG-1, also relate to neuropsychiatric symptoms (Javorsky et al., 2021; Oh and Shin, 2021) .

Several other genes that are dysregulated in mental disorders, such as DISC1, phosphodiesterase 4B (PDE4B), and neurexin-1 (NRXN1), could also be impacted by SARS-CoV-2 infection and contribute to neurotropism and inflammation in the CNS. We previously noted that increased TLR3 signaling leads to reduced DISC1 expression and aberrant neurogenesis. A recent transcriptomics study of publicly available datasets demonstrated that DISC1 is downregulated by COVID-19 (Alqutami et al., 2021) . Though the exact role that DISC1 plays in complex mental disorders is unclear, DISC1 is an important component in the formation of the immune synapse. DISC1 forms a complex with Girdin and dynein that allows for the translocation of the microtubule-organizing center to the synapse; however, in DISC1 knock-out cell lines, the MTOC fails to translocate to the immune synapse (Maskalenko et al., 2020) . The DISC1 pathway is a massive multi-step pathway of 203 genes that can be subdivided in the interactome and regulome (Teng et al., 2017) . DISC1 and the DISC1 pathway genes like PDE4B and NRXN1 are implicated in several mental health disorders (Millar et al., 2007; Korth, 2009; Hu et al., 2019) . PDE4B is found in the DISC1 interactome, and differential expression of PDE4B has also been noted in relation to COVID-19 infection (Alqutami et al., 2021) . PDE4B has been shown to regulate cytokine signaling pathways (Lugnier et al., 2021; Moolamalla et al., 2021) . Several adjunct therapies for the treatment of SARS-CoV-2 symptoms have been identified that target PDE4B (Lugnier et al., 2021; Moolamalla et al., 2021) . Studies of microRNAs as potential targets of treatments for viral infection have shown that miR-1290 is upregulated in SARS-CoV-2 infection, and this is predicted to result in downregulation of NRXN1 expression Guterres et al., 2020) .

Long-lasting pulmonary symptoms, pain, fatigue, and other symptoms stemming from coronavirus infection have been documented throughout the literature. However, currently, no studies have investigated the mechanisms concerning the long-lasting mental health symptoms or disorders that might result from COVID-19 infection. However, several publications have enumerated observations of long-COVID neuropsychiatric symptoms and life stressors that affect mental health (Crook et al., 2021) . One published review listed several probable risk factors related to PTSD and psychological dysfunction, including isolation, loss of a loved one, disability, and occupation (Boyraz, 2020 ). An investigation of1,427 United States adults reported the percentage of respondents reporting depressive symptoms increased from 27.8% in early 2020 to 32.8% just 1 year later (Ettman et al., 2021) .

It is unclear what the precise causes of long COVID or neuropsychiatric symptoms could be the result of neuroinvasion by coronavirus in the brain and CNS or could result from systemic inflammation or a combination of both. There are conflicting studies regarding the specific ability of coronaviruses to cross the blood-brain barrier and infect the CNS or to be transmitted from neuron to neuron via the olfactory bulb (Thye et al., 2022) . However, clinical observations of anosmia and encephalitis would suggest that SARS-CoV-2 and other coronaviruses are capable of both (Mondelli and Pariante, 2021 ). The precise mechanisms leading to long-term psychological sequelae are yet elusive. Some investigators have concluded that there may be myriad factors contributing to long COVID cases, including prolonged inflammation, ischemia, neuroinvasion, prolonged sedation, etc. (Alonso-Lana et al., 2020; Song et al., 2020) . Given the comorbidity between autoimmune disorders and mental disorders and observations of increased levels of proinflammatory factors in the absence of encephalitis, it seems that inflammation is likely the underlying cause (Soria et al., 2018; Alonso-Lana et al., 2020; Proal and VanElzakker, 2021) .

Several animal models suitable to the study of COVID-19 are currently available. Among these models are rhesus macaques, ferrets, mice expressing the human ACE2 receptor, and Golden Syrian hamsters (Jia et al., 2021) . All these animal models feature pathological symptoms related to human pathological symptoms encountered with COVID-19. These symptoms include mild to moderate pneumonia, increased inflammatory markers, and weight loss. However, only two of these models are commonly utilized to investigate behavioral phenotypes: rhesus macaques and mice. Rhesus macaques are animal models that are used to investigate mental disorders such as anxiety. Many studies utilize transgenic mice to investigate obsessive-compulsive disorder (OCD), depression, SCZ, and ASD.

In this review, we summarized several host factors and pathways that are involved in coronavirus infection and are also implicated in neuropsychiatric symptoms. Though several of these host factors are expressed in the CNS, we have also provided evidence that their influence on widespread systemic inflammation may play a significant role in the development of long-term psychological symptoms stemming from COVID-19 infection. We've highlighted several cellular mechanisms that are impacted by SARS-CoV-2 infection and connected them to complex mental disorders such as MDD, SCZ, and BPD. We have elucidated the connection between DISC1 and DISC1 pathway proteins such as NRXN1 and PDE4B to viral infection as well as to mental disorders.

Future work should focus on the mechanisms by which infectious diseases like COVID-19 may impact mental illnesses of neuropsychiatric symptoms. This knowledge could contribute to interventions to lessen the effects of infection on the central nervous system or inform the development of treatments for existing mental disorders. Some of the host factors described here are already being investigated for their potential use as therapies or co-therapies for mental illness symptoms. However, further investigation is necessary to determine what impact coronavirus and other flu-like infections may have on mental symptoms and disorders. These investigations could elucidate the biological changes underlying the etiology of complex mental illnesses like SCZ, BPD, and depression. 

IL-17a signaling in neurons

Bivariate genome-wide association analyses of the broad depression phenotype combined with major depressive disorder, bipolar disorder or schizophrenia reveal eight novel genetic loci for depression

Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?

Calmodulin-dependent regulation of neurotransmitter release differs in subsets of neuronal cells

Analysis of shared heritability in common disorders of the brain

Infectious agents associated with schizophrenia: a meta-analysis

SLC6A20 transporter: a novel regulator of brain glycine homeostasis and NMDAR function

The SARS-CoV-2 nucleocapsid protein and its role in viral structure, biological functions, and a potential target for drug or vaccine mitigation

Dual role of autophagy in diseases of the central nervous system

Autoimmunity, inflammation, and psychosis: a search for peripheral markers

Expression of the SARS-CoV-2 entry proteins, ACE2 and TMPRSS2, in cells of the olfactory epithelium: identification of cell types and trends with age

Increased depressive ratings in patients with hepatitis C receiving interferon-α-based immunotherapy are related to interferon-αinduced changes in the serotonergic system

Why severe COVID-19 patients are at greater risk of developing depression: a molecular perspective

Coronavirus disease (COVID-19) and traumatic stress: probable risk factors and correlates of posttraumatic stress disorder critical thinking view project

Estrogen and androgen receptor inhibitors: unexpected allies in the fight against COVID-19

Schizophrenia and sex hormones: what is the link? Front

Anosmia in COVID-19: underlying mechanisms and assessment of an olfactory route to brain infection

Cloning and characterization of neuropilin-1-interacting protein: a PSD-95/Dlg/ZO-1 domain-containing protein that interacts with the cytoplasmic domain of neuropilin-1

DPP4-deficient congenic rats display blunted stress, improved fear extinction and increased central NPY

Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity

Acute variations of cytokine levels after antipsychotic treatment in drug-naïve subjects with a first-episode psychosis: a meta-analysis

Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii

SARS-CoV-2 mediated endothelial dysfunction: the potential role of chronic oxidative stress

TLR 3 downregulates expression of schizophrenia gene Disc1 via MYD 88 to control neuronal morphology

The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in the human and mouse brains

miRDB: an online database for prediction of functional microRNA targets

Differential gene expression profiles in the hippocampus of senescence-accelerated mouse

Traumatic brain injury in mice induces changes in the expression of the XCL1/XCR1 and XCL1/ITGA9 axes

Evidence for association of hyperprolinemia with schizophrenia and a measure of clinical outcome

The impact of the COVID-19 pandemic on mental disorders. A critical review

Androgen regulation of the TMPRSS2 gene and the effect of a SNP in an androgen response element

Association of sex hormones and sex hormone-binding globulin with depressive symptoms in postmenopausal women: the multi-ethnic study of atherosclerosis

The cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine-receptor system

Hormone profile in acute psychotic disorders: a cross-sectional comparison of serum hormone concentrations in treated and untreated male patients with schizophrenia

The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade

Long covidmechanisms, risk factors, and management

Neuropilin-1 is a host factor for SARS-CoV-2 infection

The expression and polymorphism of entry machinery for covid-19 in human: juxtaposing population groups, gender, and different tissues

Chemokine gene variants in schizophrenia

Innate immune response is differentially dysregulated between bipolar disease and schizophrenia

Commentary: GSK-3 inhibition as a therapeutic approach against SARs CoV2: dual benefit of inhibiting viral replication while potentiating the immune response

Functional implications of the IL-23/IL-17 immune axis in schizophrenia

An inflammatory cytokine signature predicts COVID-19 severity and survival

Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease

The role of BDNF in the development of fear learning

Common genetic variation in humans impacts in vitro susceptibility to SARS-CoV-2 infection

ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19

The nucleocapsid protein of SARS-CoV-2: a target for vaccine development

Autoimmune diseases, bipolar disorder, and non-affective psychosis

Cascading from SARS-CoV-2 to Parkinson's disease through protein-protein interactions

Persistent depressive symptoms during COVID-19: a national, population-representative, longitudinal study of U.S. adults

Furin protease: from SARS CoV-2 to anthrax, diabetes, and hypertension

Gene expression elucidates functional impact of polygenic risk for schizophrenia

Human cathepsin V protease participates in production of enkephalin and NPY neuropeptide neurotransmitters

Cathepsin L participates in the production of neuropeptide Y in secretory vesicles, demonstrated by protease gene knockout and expression

Growth arrest and DNA-damage-inducible, beta (GADD45b)-mediated DNA demethylation in major psychosis

GBD 2016 Disease and Injury Incidence and Prevalence Collaborators

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study

Protective axis of the renin-angiotensin system in the brain

A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression

Are neuropeptides relevant for the mechanism of action of SSRIs?

Cathepsin L in COVID-19: from pharmacological evidences to genetics

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

Gene expression analysis of novel genes in the prefrontal cortex of major depressive disorder subjects

Sexual divergence in activity-dependent neuroprotective protein impacting autism, schizophrenia, and Alzheimer's disease

What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19?

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

Lithium chloride inhibits the coronavirus infectious bronchitis virus in cell culture

Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism

Immediate and long-term consequences of COVID-19 infections for the development of neurological disease

TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein

SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor

Abnormalities in chemokine levels in schizophrenia and their clinical correlates

Cathepsin B in neurodegeneration of Alzheimer's disease, traumatic brain injury, and related brain disorders

A study of TNF pathway activation in schizophrenia and bipolar disorder in plasma and brain tissue

Schizophreniaassociated rs4702 G allele-specific downregulation of FURIN expression by miR-338-3p reduces BDNF production

SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract

MIR-338-3p regulates neuronal maturation and suppresses glioblastoma proliferation

Genetic insights and neurobiological implications from NRXN1 in neuropsychiatric disorders

Overdispersed gene expression in schizophrenia

SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells

Molecular docking between human tmprss2 and sars-cov-2 spike protein: conformation and intermolecular interactions

Cellular and molecular pathways of COVID-19 and potential points of therapeutic intervention

Hyperprolinemia is a risk factor for schizoaffective disorder

SARS-CoV-2, an underestimated pathogen of the nervous system. SN Compr

Emerging theme: cellular PDZ proteins as common targets of pathogenic viruses

Structural basis of coronavirus E protein interactions with human PALS1 PDZ domain

ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia

The mechanisms and animal models of SARS-CoV-2 infection

Association of ADAM10 and CAMK2A polymorphisms with conduct disorder: evidence from family-based studies

Olfactory processing in bipolar disorder, major depression, and anxiety

Association of HLA locus alleles with posttraumatic stress disorder

Chemokines and chemokine receptors during COVID-19 infection

Role of Toll-like receptors in the pathogenesis of COVID-19

Identification of senescent cell surface targetable protein DPP4

Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system

Involvement of SMARCA2/BRM in the SWI/SNF chromatin-remodeling complex in schizophrenia

Neuroimmune mechanisms and sex/gender-dependent effects in the pathophysiology of mental disorders

DISCopathies: brain disorders related to DISC1 dysfunction

ActiveDriverDB: human disease mutations and genome variation in post-translational modification sites of proteins

SARS-CoV-2-specific virulence factors in COVID-19

Toll-like receptors in the pathogenesis of neuroinflammation

Aberrant H3.3 dynamics in NAc promote vulnerability to depressivelike behavior

Sumoylation of the nucleocapsid protein of severe acute respiratory syndrome coronavirus

Detection of the nucleocapsid protein of severe acute respiratory syndrome coronavirus in serum: comparison with results of other viral markers

The MERS-CoV receptor DPP4 as a candidate binding target of the SARS-CoV-2 spike

Toll-like receptor signaling

Association of HLA class I with severe acute respiratory syndrome coronavirus infection

Integrated analysis of summary statistics to identify pleiotropic genes and pathways for the comorbidity of schizophrenia and cardiometabolic disease. Front

Toll of mental disorders: TLR-mediated function of the innate immune system

Decreased serum oxytocin and increased homocysteine in first-episode schizophrenia patients. Front

Arid1a regulates neural stem/progenitor cell proliferation and differentiation during cortical development

PDE4 inhibition as a therapeutic strategy for improvement of pulmonary dysfunctions in Covid-19 and cigarette smoking

Genome-wide association study of NMDA receptor coagonists in human cerebrospinal fluid and plasma

Differential neuregulin 1 cleavage in the prefrontal cortex and hippocampus in schizophrenia and bipolar disorder: preliminary findings

Global signaling effects of a schizophrenia-associated missense mutation in neuregulin 1: an exploratory study using whole genome and novel kinome approaches

Genes involved in pruning and inflammation are enriched in a large mega-sample of patients affected by schizophrenia and bipolar disorder and controls

Increased plasma levels of high mobility group box 1 protein in patients with bipolar disorder: a pilot study

The DISC1-Girdin complex -a missing link in signaling to the T cell cytoskeleton

The role of neuropilin-1 in COVID-19

Pathological sequelae of long-haul COVID

Smad anchor for receptor activation nuclear localization during development identifies Layers V and VI of the neocortex

The role of chemokines in the pathophysiology of major depressive disorder

Disrupted in schizophrenia 1 and phosphodiesterase 4B: towards an understanding of psychiatric illness

Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects

Association of estrogen receptor genes and schizophrenia: a preliminary study

Structure-based study of immune receptors as eligible binding targets of coronavirus SARS-CoV-2 spike protein

The role of ARID1B, a BAF chromatin remodeling complex subunit, in neural development and behavior

Brain, blood, cerebrospinal fluid, and serum biomarkers in schizophrenia

What can neuroimmunology teach us about the symptoms of long-COVID?

Host metabolic reprogramming in response to SARS-CoV-2 infection: a systems biology approach

Running-induced systemic cathepsin B secretion is associated with memory function

The role of androgens in COVID-19

Epitope mimicry analysis of SARS-COV-2 surface proteins and human lung proteins

The immune response and immunopathology of COVID-19

Possible neurological and mental outcomes of COVID-19 infection: a hypothetical role of ACE-2\Mas\BDNF signaling pathway

SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition

Lithium's antiviral effects: a potential drug for CoViD-19 disease?

Olfactory neurons obtained through nasal biopsy combined with lasercapture microdissection: a potential approach to study treatment response in mental disorders

Interventions that may reduce depressive symptoms among prostate cancer patients: a systematic review and meta-analysis

Association of human-leukocyte-antigen class I (B * 0703) and class II (DRB1 * 0301) genotypes with susceptibility and resistance to the development of severe acute respiratory syndrome

Lithium and coronaviral infections. A scoping review. F1000Res

SARS-CoV-2 nucleocapsid protein targets RIG-I-like receptor pathways to inhibit the induction of interferon response

Evidence for enhanced androgen action in the prefrontal cortex of people with bipolar disorder but not schizophrenia or major depressive disorder

Gonadal hormones in schizophrenia and mood disorders

The evolutionary conserved SWI/SNF subunits ARID1A and ARID1B are key modulators of pluripotency and cell-fate determination

Tolllike receptors in the depressed and suicide brain

FYCO1 is a Rab7 effector that binds to LC3 and PI3P to mediate microtubule plus end -directed vesicle transport

Molecular signature of extracellular matrix pathology in schizophrenia

HLA typing using genome wide data reveals susceptibility types for infections in a psychiatric disease enriched sample

HMGB1: a common biomarker and potential target for TBI, neuroinflammation, epilepsy, and cognitive dysfunction

The role of cysteine peptidases in coronavirus cell entry and replication: the therapeutic potential of cathepsin inhibitors

Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms

The distinct role of ADAM17 in APP proteolysis and microglial activation related to Alzheimer's disease

A review of candidate therapies for middle east respiratory syndrome from a molecular perspective

Glycogen synthase kinase-3: a putative target to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic

Modulation of autophagy by SARS-CoV-2: a potential threat for cardiovascular system

Long COVID") and diabetes: challenges in diagnosis and management

Depression and prostate cancer: examining comorbidity and male-specific symptoms

Circulating sDPP-4 is increased in obesity and insulin resistance but is not related to systemic metabolic inflammation

The role of aberrations in the immuneinflammatory response system (IRS) and the compensatory immune-regulatory reflex system (CIRS) in different phenotypes of schizophrenia: the IRS-CIRS theory of schizophrenia

Brain-derived neurotrophic factor (BDNF) and its role in the functioning of the central nervous system

Androgen signaling regulates SARS-CoV-2 receptor levels and is associated with severe COVID-19 symptoms in men

Regulation of the immune response by TGF-β: from conception to autoimmunity and infection

Testosterone levels and androgen receptor gene polymorphism predict specific symptoms of depression in young men

FYCO1 mediates clearance of α-synuclein aggregates through a Rab7-dependent mechanism

Antigen presentation in SARS-CoV-2 infection: the role of class I HLA and ERAP polymorphisms

Proprotein convertases: lessons from knockouts

Biological insights from 108 schizophrenia-associated genetic loci

Neuropeptide Y (NPY) and posttraumatic stress disorder (PTSD): a translational update

Psychiatric and neuropsychiatric sequelae of COVID-19 -A systematic review

Synergistic effects of common schizophrenia risk variants

Testosterone and myelin regeneration in the central nervous system

Influenza virus infection increases ACE2 expression and shedding in human small airway epithelial cells

What lies ahead for the proprotein convertases?

Sex steroids and the immune system

Genomewide association study of severe Covid-19 with respiratory failure

Intoxication with endogenous angiotensin II: a COVID-19 hypothesis

Will SARS-CoV-2 become endemic?

Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions

A review of neurological complications of COVID-19

The role of components of the chromatin modification machinery in carcinogenesis of clear cell carcinoma of the ovary (Review)

Different host cell proteases activate the SARS-coronavirus spikeprotein for cell-cell and virus-cell fusion

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry

Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19

The role of BAF (mSWI/SNF) complexes in mammalian neural development

Immunological and inflammatory profiles in mild and severe cases of COVID-19

Psychoneuroimmunology of mental disorders

Cellular, synaptic, and network effects of chemokines in the central nervous system and their implications to behavior

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis

Historical insight into infections and disorders associated with neurological and psychiatric sequelae similar to long COVID

Common variants conferring risk of schizophrenia

An analysis of five TrkB gene polymorphisms in schizophrenia and the interaction of its haplotype with rs6265 BDNF gene polymorphism

Dysregulation of cell signaling by SARS-CoV-2

Olfactory functioning and depression: a systematic review

6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records

Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA

Glycogen synthase kinase 3 inactivation drives T-betmediated downregulation of co-receptor PD-1 to enhance CD8+ cytolytic T cell responses

Rare disruptive variants in the DISC1 interactome and regulome: association with cognitive ability and schizophrenia

The Lancet Global Health (2020)

Psychological symptoms in COVID-19 patients: insights into pathophysiology and risk factors of long COVID-19

Neuroimmune crosstalk in the central nervous system and its significance for neurological diseases

A novel animal model for studying depression featuring the induction of the unfolded protein response in hippocampus

Unraveling the epigenetic landscape of depression: focus on early life stress

Guillain-Barré syndrome associated with SARS-CoV-2

DPP4 and ACE2 in diabetes and COVID-19: therapeutic targets for cardiovascular complications?

Endemic SARS-CoV-2 will maintain postpandemic immunity

Knowledge synthesis of 100 million biomedical documents augments the deep expression profiling of coronavirus receptors

Cysteine cathepsins and their extracellular roles: shaping the microenvironment

Calcium-binding proteins are altered in the cerebellum in schizophrenia

Estrogens, neuroinflammation, and neurodegeneration

Activation of the α-secretase processing of AβPP as a therapeutic approach in Alzheimer's disease

Neuron-specific chromatin remodeling: a missing link in epigenetic mechanisms underlying synaptic plasticity, memory, and intellectual disability disorders

Androgen sensitivity gateway to COVID-19 disease severity

Minocycline prevents the depressive-like behavior through inhibiting the release of HMGB1 from microglia and neurons

Cardiovascular protective properties of oxytocin against COVID-19

Genome-wide CRISPR screens reveal host factors critical for SARS-CoV-2 infection

Dysregulation of oxytocin and dopamine in the corticostriatal circuitry in bipolar II disorder

COVID-19 and the reninangiotensin system (RAS): a spark that sets the forest alight?

BRM-SWI/SNF chromatin remodeling complex enables functional telomeres by promoting coexpression of TRF2 and TRF1

Nervous system involvement after infection with COVID-19 and other coronaviruses

Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT/enhancer binding protein

Transgenic overexpression of furin increases epileptic susceptibility

The genome-wide risk alleles for psychiatric disorders at 3p21.1 show convergent effects on mRNA expression, cognitive function, and mushroom dendritic spine

Association of BDNF Val66MET polymorphism and brain BDNF levels with major depression and suicide

Calmodulin overexpression causes Ca2+ -dependent apoptosis of pancreatic β cells, which can be prevented by inhibition of nitric oxide synthase

The role of ADAM10 in Alzheimer's disease

HMGB1 involved in stressinduced depression and its neuroinflammatory priming role: a systematic review

New understanding of the damage of SARS-CoV-2 infection outside the respiratory system

Lithium chloride inhibits early stages of foot-and-mouth disease virus (FMDV) replication in vitro

Inhibitors of SARS-CoV entry -Identification using an internally-controlled dual envelope pseudovirion assay

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.